BCRX | BioCryst Pharmaceuticals Inc
Category: Consumer goods
Quick infos Headquarters: Durham, North Carolina, United States Trade prices Volume: Market Cap: 2.01B Prev closed: 8.2 Open: 8.12 High: 8.61 Low: 8.08 52 week low: 1.58 52 week high: 8.99 Dividends: No Dividends Next ER: August 3, 2023
About the Company BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug RAPIVAB was approved by FDA in Dec 2014.
Earnings History Date EPS / Forecast Revenue / Forecast November 8, 2023 August 3, 2023 -0.24 / -0.2381M / 81.41MMay 3, 2023 -0.28 / -0.368.4M / 71.47MFebruary 21, 2023 -0.38 / -0.166479.55M / 75.23MBeat! November 2, 2022 -0.23 / -0.2975.83M / 74.62MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Jul 28, 2023 7.68 7.65 7.88
7.57
2.0M -0.9% Jul 27, 2023 7.75 7.95 7.95
7.71
5.8M -2.15% Jul 26, 2023 7.92 7.64 7.93
7.59
2.7M 3.66% Jul 25, 2023 7.64 7.34 7.74
7.33
1.8M 3.80% Jul 24, 2023 7.36 7.48 7.56
7.31
1.4M -1.47% Jul 21, 2023 7.47 7.24 7.54
7.22
1.8M 4.18% Jul 20, 2023 7.17 7.36 7.53
7.14
2.1M -2.58% Jul 19, 2023 7.36 7.24 7.47
7.24
2.2M 2.65% Jul 18, 2023 7.17 7.15 7.28
7.1
1.5M -0.28% Jul 17, 2023 7.19 7.13 7.4
7.11
2.9M 0.84% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:1986 Employees:110 News
BioCryst: Q1 Earnings Snapshot finance.yahoo.com Aug 7, 2023 7:13 am
BioCryst: Q2 Earnings Snapshot finance.yahoo.com Aug 7, 2023 7:07 am
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2023 Earnings Call Transcript finance.yahoo.com Aug 4, 2023 4:56 pm
BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript finance.yahoo.com Aug 3, 2023 2:30 pm
Wall Street Analysts Think BioCryst (BCRX) Could Surge 107.2%: Read This Before Placing a Bet finance.yahoo.com Jul 20, 2023 9:55 am
BioCryst Selects Er-Kim Pharmaceuticals as Commercial Partner for ORLADEYO® (berotralstat) in Turkey finance.yahoo.com Jul 19, 2023 7:00 am
BioCryst to Participate in the 2023 US HAEA National Summit finance.yahoo.com Jul 17, 2023 7:00 am BioCryst Pharmaceuticals (BCRX) Q3 2022 Earnings Call Transcript fool.com Jul 14, 2023 3:00 pm
Why BioCryst Pharmaceuticals Stock Is Soaring Today finance.yahoo.com Jul 14, 2023 1:44 pm Why BioCryst Pharmaceuticals Stock Is Bolting Higher Today fool.com Jul 14, 2023 10:12 am
Parexel Appoints Peyton Howell Chief Operating and Growth Officer; Promotes FDA Veteran Amy McKee, MD, to Chief Medical Officer and Global Head, Oncology Center of Excellence finance.yahoo.com Jul 14, 2023 9:00 am
BioCryst to discontinue development of drug finance.yahoo.com Jul 14, 2023 8:52 am
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Jul 6, 2023 7:00 am
BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) institutional shareholders had a great week as one-year returns increased after a 13% gain last week finance.yahoo.com May 9, 2023 10:21 am
BioCryst Pharmaceuticals (BCRX) Reports Q4 Loss, Tops Revenue Estimates finance.yahoo.com Jul 14, 2023 8:35 am
BioCryst Reports Second Quarter 2022 Financial Results and Upcoming Key Milestones finance.yahoo.com Jul 14, 2023 7:00 am
U.S. Government Exercises Option to Purchase Additional RAPIVAB® (peramivir injection) from BioCryst for Pandemic Influenza Preparedness finance.yahoo.com Jul 14, 2023 7:00 am
FDA Grants Orphan Drug Designation for BioCrysts ALK-2 Inhibitor, BCX9250, for the Treatment of Fibrodysplasia Ossificans Progressiva finance.yahoo.com Jul 14, 2023 7:00 am
BioCryst Reports Third Quarter 2022 Financial Results and Upcoming Key Milestones finance.yahoo.com Jul 14, 2023 7:00 am
BioCryst to Present at 41st Annual J.P. Morgan Healthcare Conference finance.yahoo.com Jul 14, 2023 7:00 am This company doesn't provide a dividend.
Key Persons CEO : Jon P. Stonehouse CFO : Thomas R. Staab II Talk about BioCryst Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 44 HOLD 56 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet